GARBER ALAN M 1312907 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | 2024-03-21 | 2024-03-21 | 4 | Garber Alan M | DIRECTOR | acq | 23491.0 | 42.78 | 0.77 | 19.57 | Direct | Common Stock | EXELIXIS, INC. | code M | 54908.0 | 303.19 (EXEL) |
| 2024-03-25 | 2024-03-21 | 2024-03-21 | 4 | Garber Alan M | DIRECTOR | dsp | 19205.0 | 34.98 | 0.63 | 24.01 | Direct | Common Stock | EXELIXIS, INC. | code S | 35703.0 | 303.19 (EXEL) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-02 | 2023-06-01 | 2023-06-01 | 4 | Garber Alan M | DIRECTOR | acq | 44087.0 | 100.0 | 1.35 | 19.39 | Direct | Option (Right To Buy) | EXELIXIS, INC. | code A | 44087.0 | 325.64 (EXEL) |
| 2024-03-25 | 2024-03-21 | 2024-03-21 | 4 | Garber Alan M | DIRECTOR | dsp | 23491.0 | 100.0 | 0.77 | 19.57 | Direct | Option (Right To Buy) | EXELIXIS, INC. | code M | 0.0 | 303.19 (EXEL) |
| 2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Garber Alan M | DIRECTOR | acq | 3142.0 | 100.0 | 0.12 | 399.71 | Direct | Stock Option (Right To Buy) | VERTEX PHARMACEUTICALS INC / MA | code A | 3142.0 | 258.31 (VRTX) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)